AC BioScience secured CHF 2.5 million
21 August 2022
21 August 2022
Total investments received (USD): 3.65m
Round value (USD): 2.62m
Company: AC BioScience
Industry:
Biotech
Health services
Related deals
Bionomous raised $2.7 million Series A funding round led by Nivalis Group.
Investments
21 January 2023
Nanolive to extend series C with $2.2 million
Investments
20 September 2022
Navignostics raised CHF 1 million
Investments
21 August 2022
Invasight raised CHF 4.5 million in a round led by Occident.
Investments
05 June 2022
Bionter raised $3M in a seed funding round led by Dynamk Capital.
Investments
04 April 2022
Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom